4umr: Difference between revisions

No edit summary
No edit summary
Line 3: Line 3:
<StructureSection load='4umr' size='340' side='right'caption='[[4umr]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
<StructureSection load='4umr' size='340' side='right'caption='[[4umr]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[4umr]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UMR OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4UMR FirstGlance]. <br>
<table><tr><td colspan='2'>[[4umr]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UMR OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4UMR FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=QBB:4-FLUORO-N-(1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)BENZAMIDE'>QBB</scene></td></tr>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=QBB:4-FLUORO-N-(1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)BENZAMIDE'>QBB</scene></td></tr>
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4d2t|4d2t]], [[4d2v|4d2v]], [[4d2w|4d2w]], [[4ump|4ump]], [[4umq|4umq]], [[4umt|4umt]], [[4umu|4umu]]</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4umr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4umr OCA], [https://pdbe.org/4umr PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4umr RCSB], [https://www.ebi.ac.uk/pdbsum/4umr PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4umr ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4umr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4umr OCA], [http://pdbe.org/4umr PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4umr RCSB], [http://www.ebi.ac.uk/pdbsum/4umr PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4umr ProSAT]</span></td></tr>
</table>
</table>
== Disease ==
== Disease ==
[[http://www.uniprot.org/uniprot/MELK_HUMAN MELK_HUMAN]] Note=Defects in MELK are associated with some cancers, such as brain or breast cancers. Expression is dramatically increased in aggressive undifferentiated tumors, correlating with poor patient outcome in breast and brain cancers, suggesting a role in tumor-initiating cells and proliferation via its function in cell proliferation regulation.  
[https://www.uniprot.org/uniprot/MELK_HUMAN MELK_HUMAN] Note=Defects in MELK are associated with some cancers, such as brain or breast cancers. Expression is dramatically increased in aggressive undifferentiated tumors, correlating with poor patient outcome in breast and brain cancers, suggesting a role in tumor-initiating cells and proliferation via its function in cell proliferation regulation.
== Function ==
== Function ==
[[http://www.uniprot.org/uniprot/MELK_HUMAN MELK_HUMAN]] Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation. Has a broad substrate specificity; phosphorylates BCL2L14, CDC25B, MAP3K5/ASK1 and ZNF622. Acts as an activator of apoptosis by phosphorylating and activating MAP3K5/ASK1. Acts as a regulator of cell cycle, notably by mediating phosphorylation of CDC25B, promoting localization of CDC25B to the centrosome and the spindle poles during mitosis. Plays a key role in cell proliferation and carcinogenesis. Required for proliferation of embryonic and postnatal multipotent neural progenitors. Phosphorylates and inhibits BCL2L14, possibly leading to affect mammary carcinogenesis by mediating inhibition of the pro-apoptotic function of BCL2L14. Also involved in the inhibition of spliceosome assembly during mitosis by phosphorylating ZNF622, thereby contributing to its redirection to the nucleus. May also play a role in primitive hematopoiesis.<ref>PMID:11802789</ref> <ref>PMID:12400006</ref> <ref>PMID:14699119</ref> <ref>PMID:15908796</ref> <ref>PMID:16216881</ref> <ref>PMID:17280616</ref>
[https://www.uniprot.org/uniprot/MELK_HUMAN MELK_HUMAN] Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation. Has a broad substrate specificity; phosphorylates BCL2L14, CDC25B, MAP3K5/ASK1 and ZNF622. Acts as an activator of apoptosis by phosphorylating and activating MAP3K5/ASK1. Acts as a regulator of cell cycle, notably by mediating phosphorylation of CDC25B, promoting localization of CDC25B to the centrosome and the spindle poles during mitosis. Plays a key role in cell proliferation and carcinogenesis. Required for proliferation of embryonic and postnatal multipotent neural progenitors. Phosphorylates and inhibits BCL2L14, possibly leading to affect mammary carcinogenesis by mediating inhibition of the pro-apoptotic function of BCL2L14. Also involved in the inhibition of spliceosome assembly during mitosis by phosphorylating ZNF622, thereby contributing to its redirection to the nucleus. May also play a role in primitive hematopoiesis.<ref>PMID:11802789</ref> <ref>PMID:12400006</ref> <ref>PMID:14699119</ref> <ref>PMID:15908796</ref> <ref>PMID:16216881</ref> <ref>PMID:17280616</ref>  
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 25: Line 24:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Human]]
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
[[Category: Beke, L]]
[[Category: Beke L]]
[[Category: Berdini, V]]
[[Category: Berdini V]]
[[Category: Bonnet, P]]
[[Category: Bonnet P]]
[[Category: Brehmer, D]]
[[Category: Brehmer D]]
[[Category: Coyle, J E]]
[[Category: Coyle JE]]
[[Category: Day, P J]]
[[Category: Day PJ]]
[[Category: Frederickson, M]]
[[Category: Frederickson M]]
[[Category: Freyne, E J.E]]
[[Category: Freyne EJE]]
[[Category: Gilissen, R A.H J]]
[[Category: Gilissen RAHJ]]
[[Category: Hamlett, C C.F]]
[[Category: Hamlett CCF]]
[[Category: Howard, S]]
[[Category: Howard S]]
[[Category: Johnson, C N]]
[[Category: Johnson CN]]
[[Category: Linders, J T.M]]
[[Category: Linders JTM]]
[[Category: McMenamin, R]]
[[Category: McMenamin R]]
[[Category: Meerpoel, L]]
[[Category: Meerpoel L]]
[[Category: Patel, S]]
[[Category: Patel S]]
[[Category: Rees, D C]]
[[Category: Rees DC]]
[[Category: Sharff, A]]
[[Category: Sharff A]]
[[Category: Sommen, F]]
[[Category: Sommen F]]
[[Category: Wu, T]]
[[Category: Wu T]]
[[Category: Fragment based drug design]]
[[Category: Transferase]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA